Geode Capital Management, LLC Oncorus, Inc. Transaction History

Geode Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.28 - $0.45 $609 - $979	-2,176 Reduced 1.58%	135,751 $46,000
Q4 2022 Feb 13, 2023	SELL	$0.24 - $0.76 $71 - $227	-299 Reduced 0.22%	137,927 $34,000
Q2 2022 Aug 12, 2022	SELL	$1.04 - $1.86 $164,302 - $293,848	-157,983 Reduced 53.33%	138,226 $174,000
Q1 2022 May 13, 2022	SELL	$1.44 - $5.62 $377 - $1,472	-262 Reduced 0.09%	296,209 $527,000
Q4 2021 Feb 11, 2022	BUY	$5.03 - $11.63 $376,596 - $870,738	74,870 Added 33.79%	296,471 $1.56 Million
Q3 2021 Nov 12, 2021	SELL	$9.29 - $14.27 $248,516 - $381,736	-26,751 Reduced 10.77%	221,601 $2.07 Million
Q2 2021 Aug 13, 2021	BUY	$13.3 - $17.3 $1.58 Million - $2.05 Million	118,625 Added 91.44%	248,352 $3.43 Million
Q1 2021 May 12, 2021	BUY	$11.89 - $35.55 $153,143 - $457,883	12,880 Added 11.02%	129,727 $1.81 Million
Q4 2020 Feb 12, 2021	BUY	$15.0 - $35.15 $1.75 Million - $4.11 Million	116,847 New	116,847 $3.78 Million

Ticker ONCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,973,100
Description
Oncorus, Inc., a clinical-stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. The company's lead product candidate is ONCR-177, an intratumorally administered viral immunotherapy based on its oncolytic herpes simplex virus type 1 platform, which is in Phase I clinical trials for treating various canc...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.